Cancer Research UK Publishes Detection and Diagnosis Roadmap
Early detection of cancer must be heavily invested in according to Cancer Research UK’s new report. The ‘Roadmap for the Early Detection and Diagnosis of Cancer’ provides recommendation on cancer care and innovative techniques for future use. It argues that early detection of cancer is the single biggest opportunity for reducing mortalities from cancers going forward. However, many obstacles are blocking the roll-out of an effective early cancer diagnostic system, including investment shortages and a lack of uptake of innovative technologies into the healthcare system.
More than 100 experts, including representatives from BIVDA, were consulted in the composition of the report. The text highlighted the siloed early detection research and development ecosystem, from academia and industry to the health services and policy makers, which they see as potentially hampering progress. A set of tangible recommendations have been produced in response to these concerns. These include critical investment in diagnostic equipment and technologies. The latter are not currently been taken up by the health system quickly or widely enough for patients to benefit from potentially life-saving diagnostics and treatment technology products and approaches.
With the correct uptake of technologies, appropriate investment and willingness of health leaders to concentrate on the scaling-up of early cancer detection programmes the UK will be able to unlock a major economic growth opportunity for the UK and utilise its talent pool strength to maximise opportunities for saving lives across the NHS.
Dr David Crosby, Head of Prevention and Early Detection Research at Cancer Research UK and co-author of the Roadmap said: “All too often, patients are being diagnosed at a late stage, where their cancer is deeply rooted and requires significant intervention, often with poor outcomes”. He added that the Roadmap provides a clear pathway on how to consolidate and mobilise the entire research, commercial and health ecosystem to create a future “where lives are not needlessly lost due to late diagnosis”.